openPR Logo
Press release

Heart Valve Devices Market is Projected to Reach US$14,358.3 Million by the End of 2025

09-13-2017 02:42 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Heart Valve Devices Market is Projected to Reach US$14,358.3

The TMR report states that the international heart valve devices market is envisaged to exhibit a CAGR of 13.4% between 2016 and 2025, primarily on account of the popularity of transcatheter valves. Globally, the market stood at US$5,046.7 mn in 2016 and is projected to reach US$14,358.3 mn by the end of 2025. North America held nearly 40% of the total market share, thus emerging as the leading market player in 2016.

Being Minimally Invasive, Transcatheter Aortic Valves to Be Leading Segment

Among the various market segments of the global heart valve devices market, mechanical valves hold a leading share in terms of revenue, owing to its capabilities to minimize cell damage, do not require subsequent surgeries, and are least resistant to blood flow. However, the most growth is predicted to be registered by the transcatheter valve segment. Transcatheter valves are expected to register immense growth at a promising pace. Their immense scope of growth can be attributed to the fact that transcatheter aortic valves are minimally invasive, owing to which they completely eliminate the need for conventional surgeries.

Request to download and view full ToC - http://www.transparencymarketresearch.com/report-toc/486

North America has been the top market performer until now, and is predicted to continue holding its position, on account of brisk technology integration and surging adoption of usage of transcatheter valves. It is followed by Europe with an estimated 33.9% share of the total market share by the forecast period, owing to increasing awareness about cardiac disorders and valve repair procedures.

Rising Geriatric Population and Increasing Incidence of Heart Diseases to Create Growth Opportunities

The global market for heart valve devices is anticipated to grow consistently due to improved life spans and progress in functional attributes among patients and health care institutes across the world. Asia Pacific is predicted to showcase tremendous market growth opportunities, being a vast region of briskly emerging economies. Geriatric population with heart conditions is soaring in populous countries like China and India, and the growing percentage of adults with disposable incomes are making it easier to spend on advanced surgeries. This, in turn, is anticipated to create significant impressions on the world market opportunities. The World Health Organization reports that in the year 2012, approximately 17.5 mn individuals suffered death at the hands of cardiovascular disorders.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=486

Advent of industries like medical tourism is also predicted to cater to market growth worldwide. The market is anticipated to face some factors hindering its growth over the report’s forecast period, such as complicated regulatory procedures, high surgery costs, and stringent regulatory processes. Nonetheless, the global heart valve devices market is expected to witness a steady growth rate and plentiful market opportunities, and overcome the restraints smoothly.

A number of enterprises vying to make it to the top and achieve colossal market revenue in the global heart valve devices market. Transparency Market Research (TMR) has recently published a report that calls to attention some of the leading names in the business, such as Mediotronic cplc, Abbott Laboratories, Sorin Group, Neovasc Inc., and Edward Life Sciences Corporation. These players, along with other prominent market players are expected to be focus on research and development in the heart valve repair technology. The investment on research and development of new techniques are aimed at making heart valve repair and replacement safer and more efficient. This would also help market players strengthen their foothold in the global heart valve devices market.

Buy Global Heart Valve Devices Market Report for US$ 5795 @ http://www.transparencymarketresearch.com/checkout.php?rep_id=486<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heart Valve Devices Market is Projected to Reach US$14,358.3 Million by the End of 2025 here

News-ID: 714826 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an